Moreover, the meta-analysis suggested that HER-2 overexpression was also not correlated with lymph node metastasis (OR = 1.90, 95 % CI = 0.90–4.02, P = 0.09) (Fig. 7). Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.